Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies
Yi, Chunyan, Sun, Xiaoyu, Ye, Jing, Ding, Longfei, Liu, Meiqin, Yang, Zhuo, Lu, Xiao, Zhang, Yaguang, Ma, Liyang, Gu, Wangpeng, Qu, Aidong, Xu, Jianqing, Shi, Zhengli, Ling, Zhiyang, Sun, Bing
Published in Cellular & molecular immunology (01.06.2020)
Published in Cellular & molecular immunology (01.06.2020)
Get full text
Journal Article
Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants
Yi, Chunyan, Sun, Xiaoyu, Lin, Yixiao, Gu, Chenjian, Ding, Longfei, Lu, Xiao, Yang, Zhuo, Zhang, Yaguang, Ma, Liyan, Gu, Wangpeng, Qu, Aidong, Zhou, Xu, Li, Xiuling, Xu, Jianqing, Ling, Zhiyang, Xie, Youhua, Lu, Hongzhou, Sun, Bing
Published in Genome medicine (14.10.2021)
Published in Genome medicine (14.10.2021)
Get full text
Journal Article
TFAB002s, novel CD20-targeting T cell-dependent bispecific Fab-FabCH3 antibodies, exhibit potent antitumor efficacy against malignant B-cell lymphoma
Li, Qinghong, Zhang, Kunming, Yu, Yao, Yu, Zeng, Xu, Jingyi, Shen, Wenyan, Zhang, Lin, Qu, Aidong, Liang, Hongyuan
Published in PloS one (25.09.2024)
Published in PloS one (25.09.2024)
Get full text
Journal Article
Outcome benefits of bevacizumab biosimilar (SIBP04) combined with carboplatin and paclitaxel in advanced non-squamous non-small-cell lung cancer patients with EGFR mutation: subgroup analysis of a prospective, randomized phase III clinical trial
Qu, Aidong, Zhang, Shiying, Zou, Hongxia, Li, Sixiu, Chen, Dandan, Zhang, Yaowen, Li, Songsong, Zhang, Huijun, Yang, Ji, Yang, Yunkai, Huang, Yubao, Li, Xiuling, Zhang, Yuntao
Published in Journal of cancer research and clinical oncology (01.11.2023)
Published in Journal of cancer research and clinical oncology (01.11.2023)
Get full text
Journal Article
Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2
Sun, Xiaoyu, Yi, Chunyan, Zhu, Yuanfei, Ding, Longfei, Xia, Shuai, Chen, Xingchen, Liu, Mu, Gu, Chenjian, Lu, Xiao, Fu, Yadong, Chen, Shuangfeng, Zhang, Tianlong, Zhang, Yaguang, Yang, Zhuo, Ma, Liyan, Gu, Wangpeng, Hu, Gaowei, Du, Shujuan, Yan, Renhong, Fu, Weihui, Yuan, Songhua, Qiu, Chenli, Zhao, Chen, Zhang, Xiaoyan, He, Yonghui, Qu, Aidong, Zhou, Xu, Li, Xiuling, Wong, Gary, Deng, Qiang, Zhou, Qiang, Lu, Hongzhou, Ling, Zhiyang, Ding, Jianping, Lu, Lu, Xu, Jianqing, Xie, Youhua, Sun, Bing
Published in Nature microbiology (01.07.2022)
Published in Nature microbiology (01.07.2022)
Get full text
Journal Article
Modified response evaluation criteria in solid tumors: A better response evaluation criteria for patients with non-squamous non-small cell lung cancer after bevacizumab treatment
Huang, Yubao, Yang, Yunkai, Qu, Aidong, Li, Sixiu, Chen, Dandan, Zou, Hongxia, Li, Songsong, Zhang, Yaowen, Zhuang, Wei, Su, Jing, Zhou, Xu, Zhang, Yuntao
Published in Asia-Pacific journal of clinical oncology (01.02.2024)
Published in Asia-Pacific journal of clinical oncology (01.02.2024)
Get full text
Journal Article
Abstract 6435: BCG008, a human Siglec-15 blocking antibody, displays potent anti-tumor activity in Siglec-15-humanized mice
Yang, Yongfei, Qu, Aidong, Yao, Fengping, Song, Pan, Liang, Hongyuan, Tian, Maopeng, Yang, Fang, Yu, Zhaoxue, Zhou, Xu, Li, Xiuling
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article
Crystal structure of the I-domain from the CD11a/CD18 (LFA-1, alpha sub(L) beta 2) integrin
Qu, Aidong, Leahy, D J
Published in Proceedings of the National Academy of Sciences - PNAS (24.10.1995)
Published in Proceedings of the National Academy of Sciences - PNAS (24.10.1995)
Get full text
Journal Article
Crystal Structure of the I-Domain from the CD11a/CD18 (LFA-1, αLβ2) Integrin
Qu, Aidong, Leahy, Daniel J.
Published in Proceedings of the National Academy of Sciences - PNAS (24.10.1995)
Published in Proceedings of the National Academy of Sciences - PNAS (24.10.1995)
Get full text
Journal Article
Anti-HER3 humanized monoclonal antibody
Lu, Jin, Xu, Fanhong, Zhu, Jingye, Song, Xiaofei, Liang, Hongyuan, Qu, Aidong, Zhang, Lin, Li, Aoxiang, Qiu, Jianhua, Zhao, Xin, Wu, Lina
Year of Publication 23.04.2024
Get full text
Year of Publication 23.04.2024
Patent
ANTIBODY-DRUG CONJUGATE AND USE THEREOF
QIU, Jianhua, LIANG, Hongyuan, ZHU, Jingye, ZHOU, Xu, QU, Aidong, SHEN, Wenyan
Year of Publication 18.09.2024
Get full text
Year of Publication 18.09.2024
Patent
ANTI-SIGLEC15 ANTIBODIES AND USES THEREOF
LIANG, Hongyuan, YAO, Fengping, YANG, Yongfei, LI, Xiuling, QU, Aidong, SONG, Pan
Year of Publication 21.12.2023
Get full text
Year of Publication 21.12.2023
Patent
METHOD FOR DETECTING DIFFERENTIATED RNA EDITING SITES
ZHANG, Kunming, QIU, Jianhua, LIANG, Hongyuan, QU, Aidong, ZHANG, Chi
Year of Publication 13.06.2024
Get full text
Year of Publication 13.06.2024
Patent
ANTI-HER3 HUMANIZED MONOCLONAL ANTIBODY
LU, Jin, QIU, Jianhua, LIANG, Hongyuan, ZHU, Jingye, XU, Fanhong, LI, Aoxiang, QU, Aidong, SONG, Xiaofei, WU, Lina, ZHANG, Lin, ZHAO, Xin
Year of Publication 10.11.2021
Get full text
Year of Publication 10.11.2021
Patent
ANTI-HER3 HUMANIZED MONOCLONAL ANTIBODY
LU, Jin, QIU, Jianhua, LIANG, Hongyuan, ZHU, Jingye, XU, Fanhong, LI, Aoxiang, QU, Aidong, SONG, Xiaofei, WU, Lina, ZHANG, Lin, ZHAO, Xin
Year of Publication 09.09.2021
Get full text
Year of Publication 09.09.2021
Patent
ANTIBODY-DRUG CONJUGATE AND USE THEREOF
QIU, Jianhua, LIANG, Hongyuan, ZHU, Jingye, ZHOU, Xu, QU, Aidong, SHEN, Wenyan
Year of Publication 08.06.2023
Get full text
Year of Publication 08.06.2023
Patent
Antibody drug conjugates and uses thereof
SHEN WENYAN, QIU JIANHUA, QU AIDONG, LIANG HONGYUAN, ZHU JINGYE, ZHOU XU
Year of Publication 02.06.2023
Get full text
Year of Publication 02.06.2023
Patent